http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102614198-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40285e27f4ed83b8728b0d477404958
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-625
filingDate 2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7632d61a34a5d80c9aab67bdd3ecc14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f77681c1df2ed526dbe2f69cc9bbbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a23a325c267c15221aef426255b777b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91388bf07741eb73a8847b3d48c4c5bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871b03cc513fbda20547fdc40c06d732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1fe592bb382892a00d62f005a10283b
publicationDate 2012-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102614198-A
titleOfInvention Application of (4-substituted benzoyl) fluorophenyl salicylamide compounds in the preparation of anti-lung cancer drugs
abstract The invention discloses the application of a (4-substituted benzoyl) phenyl salicylamide compound represented by formula (II) in the preparation of anti-lung cancer drugs. The beneficial effects of the present invention are mainly reflected in that a (4-substituted benzoyl)fluorophenyl salicylic amide compound with anti-human lung cancer effect is provided, which provides a research basis for new drug screening and has great application prospects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015127137-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800225-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800226-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106748997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800226-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800228-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800227-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800228-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106748914-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588716-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588716-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9879036-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800225-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106748914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106458910-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104800227-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106458910-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588759-A
priorityDate 2012-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101955442-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466577423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466746734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466577424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466576805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466746730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466746735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3059

Total number of triples: 44.